Aerosolization of antibodies, proteins, and peptides is just the beginning of what can be delivered by our sonic technology. Sonic LDI is an exciting new class of pulmonary delivery technology. More
Athersys is a functional genomics and biopharmaceutical company engaged in the study of gene function and the development and application of novel research tools and therapeutic products. More
Drug inhaler devices for pulmonary and nasal delivery of dry powder formulations. Research tool for absorption/bioavailibility of oral dosage forms. Contract development and testing. More
Respirics, Inc. was founded in 2001 to provide innovative pulmonary drug delivery systems, including the formulation and development of novel and existing drugs for administration to the lung. More
Preventing drug-receptor down-regulation, desensitization or tachyphylaxis with agonist/antagonist combinations. Modeling the biophysical parameters of the drug-receptor response. More
Displaying 11..18 of 18 -
per page
Previous page
Order by
All rights reserved. Terms and Conditions | Contact us
